2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
2
Sponsor
Conditions
Leiomyoma
2
Hemorrhage
2
Sexual Infantilism
1
Polycystic Ovary Syndrome
1
Neoplasm Metastasis
1
Myoma
1
Myofibroma
1
Diabetes Insipidus
1
Craniopharyngioma
1
Blood Loss, Surgical
1
Adenomyosis
1
Interventions
ulipristal acetate
20
Uterine Myomectomy
19
telapristone acetate
18
vilaprisan
12
relugolix
12
Leuprolide
11
Uterine Artery Embolization
10
estradiol, norethindrone drug combination
9
asoprisnil
9
Estradiol
8
elagolix
7
Tranexamic Acid
7
Mifepristone
7
Bupivacaine
7
ulipristal
6
Norethindrone Acetate
6
Hysterectomy
6
Saline Solution
5
linzagolix
4
epigallocatechin gallate
4
Sodium Chloride
4
Misoprostol
4
Letrozole
4
Vitamin B 6
3
Tablets
3
Surveys and Questionnaires
3
Sugars
3
Radiofrequency Ablation
3
Lidocaine
3
Hysteroscopy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Leiomyoma
×
Oxytocin
×
Clear all
NCT04996498
2023-11-07
oxytocin
Ain Shams Maternity Hospital
Phase NA
Completed
60 enrolled
NCT03937401
2019-05-03
Oxytocin in MRI-HIFU
Turku University Hospital
Phase 4
Unknown
100 enrolled